BANK VONTOBEL/CALL/ROCHE GS/300/0.02/21.06.24 Share Price

Warrant

WROBXV

CH1225203368

Market Closed - Bid/Ask 16:20:00 25/01/2024 GMT After market 16:15:00
0.02 CHF -9.09% Intraday chart for BANK VONTOBEL/CALL/ROCHE GS/300/0.02/21.06.24 0.011 -45.00%
1 month-23.08%
3 months-47.37%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WROBXV
ISINCH1225203368
Date issued 15/12/2022
Strike 300 CHF
Maturity 21/06/2024 (35 Days)
Parity 50 : 1
Emission price 0.51 CHF
Emission volume N/A
Settlement physical
Currency CHF

Technical Indicators

Highest since issue 0.445 CHF
Lowest since issue 0.02 CHF
Spread 0.018 CHF
Spread %90.00%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
234.8 CHF
Average target price
279.4 CHF
Spread / Average Target
+18.99%
Consensus
  1. Stock Market
  2. Warrants
  3. WROBXV Warrant